# Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions

> **NCT02956512** · PHASE1 · COMPLETED · sponsor: **Apsen Farmaceutica S.A.** · enrollment: 52 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Dexibuprofen

## Key facts

- **NCT ID:** NCT02956512
- **Lead sponsor:** Apsen Farmaceutica S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-18
- **Primary completion:** 2019-07-12
- **Final completion:** 2019-09-06
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2020-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02956512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02956512, "Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02956512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*